Mexico Health Review 2020 Issuu
Mexico Health Review is your doorway to the elite of Mexico’s health industry. Take advantage of this opportunity to get inside the minds of the leaders who are shaping the industry, including public sector decision-makers, domestic and international C-level executives, top regulators and key voices in the pharmaceutical, medical device, pharmacies, hospital, insurance and other sectors.
HOW WE DO IT:
- Cutting-edge information based on more than 200 interviews with the most influential business leaders in the Mexican health industry, the country’s political leaders and key policymakers
- Dedicated editorial team with experience covering Mexico’s health industry and in-depth understanding of global trends, technological advances and international best practices, as well as, local changes and trend topics
- Uniquely customized readership that ensures unparalleled reach among key health industry participants
CHANGES IN THE SECTOR BRING NEW BUSINESS OPPORTUNITIES AND REINVENT THE ROLE OF STAKEHOLDERS
The Mexican healthcare sector has been through a roller-coaster 2019. Budget cuts have limited public sector maneuverability and uncertainty has made many investors cautious regarding short-term expansion and investment plans. While the hurdles have been significant, the Mexican economy remains steady and the local market for pharmaceuticals and medical devices shows promise. The current administration led by President Andrés Manuel López Obrador positioned universal healthcare at the top of the agenda, along with the need to address the rise in chronic diseases and to counterattack corruption in the system.
Among the industry’s buzzwords and phrases at this time of change are Big Data, analytics, innovation and technology interoperability. As Industry 4.0 practices penetrate the health sector, one key hurdle stands in the way: Mexico’s fragmented system, which makes it difficult to share data and achieve the data integration that characterizes Industry 4.0.
Healthcare is also essential for the country’s economic growth. As the industry opens further to private investment, the opportunities are many. Both old and new companies are entering or expanding in the market, attracted by the country’s large population and its changing epidemiological profile, which will only increase the need for new healthcare services. Moreover, many are investing in innovative solutions or technologies to better identify existing challenges and develop comprehensive strategies to solve them, while optimizing resources and keeping bottom lines in the black. Nevertheless, Mexico’s demographic and political changes promise new business opportunities and roles of participation for key stakeholder in the sector.
Mexico Health Review 2019 is a comprehensive report on the state of the industry, the key developments that have shaped the past year and most importantly, a signpost for the direction in which this key sector is moving.